Company / Net Income
PALVELLA THERAPEUTICS, INC. Net Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$17.4M
FY2024
5-year range
-$37.2M / $18.7M
FY2020-FY2024
Trend
-193.3%
vs FY2023
Sector context
#70 of 216
Health Care
What the data says
At -$17M, PALVELLA THERAPEUTICS, INC.'s net income ranks #70 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$37M in FY2021 to $19M in FY2023.
Based on SEC 10-K filings.
-$17M in FY2024.
Improved from -$33M to -$17M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 216 in Health CareTop 32% of 216This company -$17.4M Sector average $454.1M
▼
-103.8% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 193.3% year-over-year.
- Ranks #70 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$17.4M | -193.3% |
| FY2023 | $18.7M | +156.2% |
| FY2022 | -$33.3M | +10.6% |
| FY2021 | -$37.2M | -46.2% |
| FY2020 | -$25.5M | +0.0% |
| FY2019 | -$25.5M | -44.3% |
| FY2018 | -$17.6M | +22.6% |
| FY2017 | -$22.8M | +0.0% |
| FY2016 | -$22.8M | -62.2% |
| FY2015 | -$14.1M | -42.7% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026